Jennifer Doudna

The Innovative Genomics Institute, or IGI, and the molecular and cell biology, or MCB, department, initially proposed the course in December 2016, and it was approved in summer 2017. The course was offered for the first time this past summer, and it will be offered again next summer.

The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.

CRISPR-Cas9, the gene-editing technology co-invented by a UC Berkeley professor, is again in the courts, as the University of California fights the Broad Institute, Harvard University and the Massachusetts Institute of Technology, or MIT, over patent rights that could yield billions.

Do you think you know the history of UC Berkeley and the surrounding area? Try The Daily Californian's crossword puzzle and test your knowledge.

Lawrence Berkeley National Laboratory, more commonly known as Berkeley Lab, was founded in 1931 by campus physics professor Ernest O. Lawrence and is currently located in the hills east of campus.

The breakthrough gene-editing technology CRISPR-Cas9, which was co-discovered by UC Berkeley professor of biochemistry and molecular biology Jennifer Doudna, may soon be applied to humans for the first time to treat sickle cell disease.

UC researchers have discovered an unexpected side effect in the use of the CRISPR-Cas12a protein in DNA cutting that may potentially make disease diagnostics faster and more accurate.

Two UC Berkeley professors were honored Wednesday by the National Academy of Sciences, or NAS, for their research contributions to science.

Until recently, professor Tyrone Hayes was the only faculty member of color in the UC Berkeley integrative biology department — for nearly 30 years.

The Broad Institute filed a brief Wednesday denying many of the University of California’s patent claims on CRISPR-Cas9, a groundbreaking gene editing technology.